FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980481413> ?p ?o ?g. }

• W1980481413 endingPage "551" @default.
• W1980481413 startingPage "544" @default.
• W1980481413 abstract "Background. Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disorder (PTLD) is a serious complication of lung transplantation. Besides immunosuppression the risk factors for PTLD development are largely unknown. Methods. The incidence of PTLD was ascertained in a lung transplant population consisting of 45 patients. Nine patients (20%) experienced PTLD. The clinical, histologic, and human leukocyte antigen (HLA) data were collected on all patients. The incidence of EBV infection in lymphoid tissue taken at the time of engraftment was studied by using EBV in situ hybridization. Results. All patients with PTLD had polymorphous lymphoproliferations, seven of which were polymorphous B-cell hyperplasias and two of which were polymorphous B-cell lymphomas. EBV was identified in all lesions. All patients with polymorphous B-cell hyperplasias had clinically unsuspected disease, five of which were identified at autopsy. The two polymorphous B-cell lymphoma lesions were monoclonal and regressed with immunosuppression reduction. EBV in situ hybridization on donor or recipient lymph nodes obtained at engraftment from the 45 transplant recipients showed no difference in the number of EBV positive cells in patients with and without PTLD. Cyclosporine and azathioprine dosages and cyclosporine levels were similar between patients with and without PTLD. PTLD was seen in patients with high cumulative doses of antilymphocyte globulin. Analysis of HLA status showed a predominance of HLA A2 and DR7 in the donors of the patients with PTLD, whereas donor HLA B7 was more common in patients without PTLD. Conclusions. Detailed studies are necessary to further elucidate the risk factors for PTLD development in the lung transplant population. Background. Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disorder (PTLD) is a serious complication of lung transplantation. Besides immunosuppression the risk factors for PTLD development are largely unknown. Methods. The incidence of PTLD was ascertained in a lung transplant population consisting of 45 patients. Nine patients (20%) experienced PTLD. The clinical, histologic, and human leukocyte antigen (HLA) data were collected on all patients. The incidence of EBV infection in lymphoid tissue taken at the time of engraftment was studied by using EBV in situ hybridization. Results. All patients with PTLD had polymorphous lymphoproliferations, seven of which were polymorphous B-cell hyperplasias and two of which were polymorphous B-cell lymphomas. EBV was identified in all lesions. All patients with polymorphous B-cell hyperplasias had clinically unsuspected disease, five of which were identified at autopsy. The two polymorphous B-cell lymphoma lesions were monoclonal and regressed with immunosuppression reduction. EBV in situ hybridization on donor or recipient lymph nodes obtained at engraftment from the 45 transplant recipients showed no difference in the number of EBV positive cells in patients with and without PTLD. Cyclosporine and azathioprine dosages and cyclosporine levels were similar between patients with and without PTLD. PTLD was seen in patients with high cumulative doses of antilymphocyte globulin. Analysis of HLA status showed a predominance of HLA A2 and DR7 in the donors of the patients with PTLD, whereas donor HLA B7 was more common in patients without PTLD. Conclusions. Detailed studies are necessary to further elucidate the risk factors for PTLD development in the lung transplant population." @default.
• W1980481413 created "2016-06-24" @default.
• W1980481413 creator A5012389323 @default.
• W1980481413 creator A5017354943 @default.
• W1980481413 creator A5023319163 @default.
• W1980481413 creator A5035091873 @default.
• W1980481413 creator A5039803568 @default.
• W1980481413 creator A5049970542 @default.
• W1980481413 creator A5054533558 @default.
• W1980481413 creator A5084156114 @default.
• W1980481413 creator A5088490869 @default.
• W1980481413 date "1996-05-01" @default.
• W1980481413 modified "2023-10-15" @default.
• W1980481413 title "Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation" @default.
• W1980481413 cites W122909865 @default.
• W1980481413 cites W1555720870 @default.
• W1980481413 cites W1637920030 @default.
• W1980481413 cites W1740384507 @default.
• W1980481413 cites W1874138720 @default.
• W1980481413 cites W1990845365 @default.
• W1980481413 cites W2000006294 @default.
• W1980481413 cites W2004867952 @default.
• W1980481413 cites W2011559801 @default.
• W1980481413 cites W2016548488 @default.
• W1980481413 cites W2029542710 @default.
• W1980481413 cites W2030352916 @default.
• W1980481413 cites W2038952378 @default.
• W1980481413 cites W2058768523 @default.
• W1980481413 cites W2065669447 @default.
• W1980481413 cites W2067977645 @default.
• W1980481413 cites W2071490025 @default.
• W1980481413 cites W2078834161 @default.
• W1980481413 cites W2080062050 @default.
• W1980481413 cites W2116187825 @default.
• W1980481413 cites W2137858837 @default.
• W1980481413 cites W2145141007 @default.
• W1980481413 cites W2148185719 @default.
• W1980481413 cites W2319004594 @default.
• W1980481413 cites W2341259055 @default.
• W1980481413 doi "https://doi.org/10.1016/s0039-6060(96)80265-0" @default.
• W1980481413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8619211" @default.
• W1980481413 hasPublicationYear "1996" @default.
• W1980481413 type Work @default.
• W1980481413 sameAs 1980481413 @default.
• W1980481413 citedByCount "70" @default.
• W1980481413 countsByYear W19804814132015 @default.
• W1980481413 countsByYear W19804814132018 @default.
• W1980481413 countsByYear W19804814132020 @default.
• W1980481413 countsByYear W19804814132021 @default.
• W1980481413 crossrefType "journal-article" @default.
• W1980481413 hasAuthorship W1980481413A5012389323 @default.
• W1980481413 hasAuthorship W1980481413A5017354943 @default.
• W1980481413 hasAuthorship W1980481413A5023319163 @default.
• W1980481413 hasAuthorship W1980481413A5035091873 @default.
• W1980481413 hasAuthorship W1980481413A5039803568 @default.
• W1980481413 hasAuthorship W1980481413A5049970542 @default.
• W1980481413 hasAuthorship W1980481413A5054533558 @default.
• W1980481413 hasAuthorship W1980481413A5084156114 @default.
• W1980481413 hasAuthorship W1980481413A5088490869 @default.
• W1980481413 hasBestOaLocation W19804814131 @default.
• W1980481413 hasConcept C126322002 @default.
• W1980481413 hasConcept C142724271 @default.
• W1980481413 hasConcept C203014093 @default.
• W1980481413 hasConcept C2522874641 @default.
• W1980481413 hasConcept C2776760755 @default.
• W1980481413 hasConcept C2776995267 @default.
• W1980481413 hasConcept C2779134260 @default.
• W1980481413 hasConcept C2779338263 @default.
• W1980481413 hasConcept C2780252810 @default.
• W1980481413 hasConcept C2781146716 @default.
• W1980481413 hasConcept C2781375147 @default.
• W1980481413 hasConcept C2908647359 @default.
• W1980481413 hasConcept C2911091166 @default.
• W1980481413 hasConcept C71924100 @default.
• W1980481413 hasConcept C90924648 @default.
• W1980481413 hasConcept C99454951 @default.
• W1980481413 hasConceptScore W1980481413C126322002 @default.
• W1980481413 hasConceptScore W1980481413C142724271 @default.
• W1980481413 hasConceptScore W1980481413C203014093 @default.
• W1980481413 hasConceptScore W1980481413C2522874641 @default.
• W1980481413 hasConceptScore W1980481413C2776760755 @default.
• W1980481413 hasConceptScore W1980481413C2776995267 @default.
• W1980481413 hasConceptScore W1980481413C2779134260 @default.
• W1980481413 hasConceptScore W1980481413C2779338263 @default.
• W1980481413 hasConceptScore W1980481413C2780252810 @default.
• W1980481413 hasConceptScore W1980481413C2781146716 @default.
• W1980481413 hasConceptScore W1980481413C2781375147 @default.
• W1980481413 hasConceptScore W1980481413C2908647359 @default.
• W1980481413 hasConceptScore W1980481413C2911091166 @default.
• W1980481413 hasConceptScore W1980481413C71924100 @default.
• W1980481413 hasConceptScore W1980481413C90924648 @default.
• W1980481413 hasConceptScore W1980481413C99454951 @default.
• W1980481413 hasIssue "5" @default.
• W1980481413 hasLocation W19804814131 @default.
• W1980481413 hasLocation W19804814132 @default.
• W1980481413 hasOpenAccess W1980481413 @default.
• W1980481413 hasPrimaryLocation W19804814131 @default.
• W1980481413 hasRelatedWork W1975908321 @default.

• next